Impact Biomedical, Inc. Announces U.S. Patent Allowance of

NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is...

Related Keywords

United States ,American ,Frankd Heuszel , ,Dss Inc ,Impact Biomedical Inc ,Trademark Office ,Securities Exchange ,Precedence Research ,Glycemic Sugar ,Market Impact ,Disease Treatment Market ,Treatment Market ,Sugar Production Market ,Knowledge Sourcing Intelligence ,Impact Biomedical ,Harbor Disclosure ,Securities Act ,Securities Exchange Act ,Media Contact ,Nyse Dss ,Ass ,Nc ,Biotechnology ,Ardiology ,Diabetes Research ,Issued Patent ,Ipo ,Obesity ,Sugar Substitute ,